Lecture 10- Inner Ear Diseases Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is the definition of sudden SNHL?

A

> 30 dB decrease at 3 consecutive frequencies

Rapid onset: 72 hours or less
o Instantaneous
o Rapidly progressive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the epidemiology and natural Hx of SSNHL?

A

Peak age of onset: 6th decade

M=F

Unilateral >bilateral (2%)
 When bilateral, it can occur simultaneously or years/months apart

Epidemiology
 5-20/100,000 population
 4,000 new cases per year in USA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the etiology of SSNHL?

A

Idiopathic- up to 85-90% of SSNHL
 Idiopathic: no known or defined cause

Identified at initial presentation: 10-15%

Long term follow-up: 30%

Treatment decisions made without knowing cause- need common approach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the presenting symptoms of SSNHL?

A

Aural fullness- primary presenting Sx

Noticed on awakening

Tinnitus in 70%
 Precede or concurrent

Dizziness in 40-50%
 Vertigo, imbalance, unsteadiness
 Precede, accompanying, following

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the prognosis of SSNHL?

A

Spontaneous recovery
 Partial to complete
 32-65%

Timing
 Most recovery starts within 2 weeks
 90% of all improvement within 4 weeks

Medical intervention for known causes and ISSNHL
 Timing is critical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the variables affecting the prognosis of SSNHL?

A

Severity of loss
 Greater degree of loss
 Reduced word recognition

Spontaneous recovery
 Better prognosis if recover 50% hearing first 2-weeks

Association with vertigo at onset (worst chance of recovery)

Age>40 years (worst chance of recovery)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is an autoimmune inner ear disease?

A

Cochleovestibular system is compromised by one’s own immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the differentials for AIED?

A
	Sudden deafness
	Cochlear Meniere disease
	Chronic progressive deafness of adolescence
	Presenile presbycusis
	NIHL
	Recessive hereditary deafness
	Luetic labyrinthitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Type I for AIED?

A

Organ (ear) specific

Presentation
 Rapidly progressive bilateral SNHL
• Pure-tone decline of 10-15 dB or >12% drop in WRS in 3-month period
 15% with vestibular symptoms
 Most have aural fullness & tinnitus
 No clinical evidence of other autoimmune disease
 Negative serology for ANA, ESR, RF

Epidemiology
	“Rare”
	M=F
	All ages, mid-50s most common
	More common in white (non-Hispanic) population
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the therapeutics for AIED?

A

Corticosteroids
o Trial of oral prednisone x30 days and retest hearing
o If hearing improves:
 Taper off steroids
 Monthly hearing assessment
 When dose reaches 10 mg/day, continue at this level x3 months before D/c
o If hearing declines during, continue at current dose for another month or increase dose back up until HL stabilizes
o Total treatment time: 6-12 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are AIED therapeutic outcomes?

A

Successful taper off corticosteroids and no their hearing problems

Successful taper with relapse or gradual, progressive HL over years

Steroid dependent
o Hearing stable while on steroids
o Declines when dose gets too low
o May benefit from other immumodulatory drugs
 TNF-  inhibitor- examples include etanercept, infliximab

Steroid resistant
o Il-1 receptor antagonist – anakinra (recent promise)

Although rare, AIED is one of few examples of potentially reversible SNHL. Important to diagnose and treat, and pursue new treatments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is autoimmune SNHL diagnosed?

A

History
o Complaint of hearing loss
o Onset/progression important in differential

PE
o Normal otoscopic exam- ASHNL
o Abnormal in some systemic immune disease

Audiologic and vestibular w/u
o	SNHL: many degrees, may fluctuate
o	CHL, MHL in some systemic immune diseases
o	ABR to R/o 8th nerve lesion
o	VNG to assess vestibular function

Imaging
o MRI with and without gadolinium, attention to IAC

Serologic testing
o	Western blot
	Looking for cochlear antibody
	More likely to be abnormal in active disease
o	FTA-abs to rule out syphilis
o	ESR
o	Rheumatoid factor
o	ANA
o	Lyme titer
o	HIV testing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the different viral causes of hearing loss?

A

Congenital
o CMV
o Rubella
o Lymphocytic choriomeningitis virus

Congenital and Acquired
o HIV and HSC

Acquired
o	Measles
o	Varicella Zoster Virus
o	Mumps
o	West Nile Virus
o	Zika Virus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What types of hearing loss can result from viruses?

A

Typically SNHL

Can cause CHL, mixed, retrocochlear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the mechanisms of injury in viral hearing loss?

A
  • Direct viral damage to inner ear
  • Immune system mediated damage
  • Immunocompromise leading to 2o infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are treatment and prevention options for viral hearing loss?

A
  • Vaccines
  • Antivirals
  • Amplification
17
Q

What is the auditory presentation of hearing loss related to HIV?

A

o Prevalence: 14-49% have auditory symptoms
o Unilateral or bilateral
o CHL, MHL, or SNHL (Sensorineural in 2/3 children with HL (Uganda))
o Progressive or sudden
o Tinnitus

18
Q

What is the presentation of conductive hearing loss related to HIV?

A
o	Recurrent OM
o	Otitis externa
o	Acquired aural atresia
o	Cholesteatoma
o	Malignancy
19
Q

What is the presentation of SNHL related to HIV?

A

o Direct damage to the auditory system
o Opportunistic infections
o Treatment with potentially ototoxic medications
o Typically mild to moderate, predominantly HF

20
Q

What is acquired measles?

A
  • Rubeola virus

* Route of transmission: respiratory secretions

21
Q

How is acquired measles diagnosed?

A

o Fever, cough, nasal congestion, conjunctivitis
o Erythematous maculopapular rash
o Pathognomonic Koplik spots on the buccal mucosa

22
Q

What is the hearing loss and vestibular function associated with acquired measles?

A

o Prior to vaccination: 4-9% of severe to profound childhood HL
o Sudden onset at time of rash
o Bilateral, moderate to profound, permanent SNHL
o Otitis media incidence: 8.5-25%
o 70% reduced caloric responses in one or both ears

23
Q

What is the relationship between acquired measles and otosclerosis?

A

o Measles antigens within otosclerotic lesions
o Histology of stapes footplate- suggestive of measles infection
o Rates of otosclerosis higher in those without vaccination

24
Q

What is acquired mumps?

A
  • Paramyxovirus family

* Route of transmission: respiratory secretions

25
Q

How is acquired mumps diagnosed?

A

Based on clinical presentation/salivary anti-IgM testing

o Flu-like symptoms followed by bilateral parotiditis

26
Q

What is the hearing loss associated with acquired mumps?

A

o 4-5 days after onset of symptoms
o Unilateral in 80%
o Most often reversible, but can be permanent
o Reversible vestibular dysfunction- reduced/absent caloric response

27
Q

What is the proposed mechanism of SNHL associated with acquired mumps?

A

o Strophy of HC and SV

o Damage to myelin sheath around CN8

28
Q

What is the risk of HL associated with acquired mumps?

A

o Not correlated with severity of infection or presence of parotiditis
o Can have asymptomatic mumps associated with HL

29
Q

How does labyrinthitis affect the auditory and vestibular systems?

A

Bacteria and fungi damage to peripheral auditory and vestibular systems through:
o Suppurative labyrinthitis
o Toxic labyrinthine damage via round window or modiolus
o Purulent exudate or infectious agent
 Enveloping CN VIII
 Via cochlea aqueduct from infected CSF

30
Q

What is the acute phase of labyrinthitis?

A

Severe SNHL and vertigo

31
Q

What is the prognosis of auditory and vestibular symptoms associated with labyrinthitis?

A
  • Hearing loss is permanent

* Vertigo slowly resolves over weeks to months